Neurological Monitoring During Extracorporeal Membrane Oxygenation
Neurological complications are frequent during extracorporeal membrane oxygenation (ECMO) representing a crucial factor for patient outcome. However, to date there is no consensus with regard to optimal neurological monitoring of patients undergoing ECMO.
The aim of this study is to monitor patients using transcranial Doppler (TCD) ultrasound and near-infrared spectroscopy (NIRS) during ECMO therapy.
The study hypothesis is that TCD and NIRS technology are sufficient tools to detect cerebral embolism and hypoperfusion during ECMO therapy.
|Complication of Extracorporeal Membrane Oxygenation Cerebral Embolism Cerebral Hypoperfusion||Device: Transcranial Doppler Ultrasound|
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Multimodal Neurological Monitoring in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO) - a Prospective Observational Pilot Study.|
- Cerebral embolic load [ Time Frame: 30 minutes ]Cerebral embolic load (solid and gaseous) is measured in a 30 minutes-interval during ECMO usage
- Regional cerebral oxygenation [ Time Frame: 30 minutes ]Regional cerebral oxygenation is measured in a 30 minutes-interval during ECMO usage.
|Study Start Date:||December 2013|
|Estimated Study Completion Date:||March 2018|
|Estimated Primary Completion Date:||February 2018 (Final data collection date for primary outcome measure)|
Patient on ECMO
Device: Transcranial Doppler Ultrasound
Transcranial Doppler Ultrasound is used to monitor cerebral embolism Near-Infrared Spectroscopy is used to detect cerebral hypoperfusion
Other Name: Near-Infrared Spectroscopy
Please refer to this study by its ClinicalTrials.gov identifier: NCT02020759
|Contact: Gabor Erdoes, MD||0043 1 40400 ext email@example.com|
|Contact: Ulrich Klein, MD||0043 1 40400 ext firstname.lastname@example.org|
|Medical University of Vienna||Recruiting|
|Vienna, Austria, 1090|
|Contact: Gabor Erdoes, MD 0043 40400 ext 4102 email@example.com|
|Contact: Klaus Markstaller, Md, PhD 0043 40400 ext 4102 firstname.lastname@example.org|
|Principal Investigator: Gabor Erdoes, MD|
|Principal Investigator:||Gabor Erdoes, MD||Medical University of Vienna|